Infections After Kidney Transplantation From Donors With HIV to Recipients With HIV.
Mar 17, 2026DOI: 10.1093/cid/ciaf656Journal ArticleCID
Written by: Elizabeth C ArantThibaut Davy-MendezTao LiangMoreno RodriguesCynthia L GayMeenakshi M RanaRachel Friedman-MoracoAlexander GilbertPeter StockSapna A MehtaShikha MehtaValentina StosorMarcus R PereiraMichele I MorrisJonathan HandSaima AslamMaricar MalinisGhady HaidarCatherine B SmallCarlos A Q SantosJoanna SchaenmanJohn W BaddleyDavid WojciechowskiEmily A BlumbergKarthik RangannaOluwafisayo AdebiyiNahel EliasJose A Castillo-LugoEmmanouil GiorgakisSenu ApewokinMegan MorsheimerChristian van DeldenOriol ManuelNicolas J MuellerDionysios NeofyotosAaron A R TobianAllan MassieDorry L SegevWilliam WerbelChristine M Durand
Find these authors on Roon
SM
Dr. Sapna A. Mehta
Transplant/Immunocompromised States · NYU Langone
JS
Dr. Joanna Schaenman
Transplant/Immunocompromised States · UCLA
Summary
BACKGROUND: Kidney transplantation (KT) from donors with human immunodeficiency virus (HIV-1) to recipients with HIV (HIV D+/R+) is noninferior to KT from donors without HIV (HIV D-/R+) with regard to safety. However, there may be differences in posttransplant infections.METHODS: We performed a secondary analysis of the HOPE in Action KT Study (NCT02602262) comparing the time to first clinically relevant infection within 24 months posttransplantation in 99 HIV D+/R+ versus 99 HIV D-/R+. Secondary outcomes included incidence rates, infection-related death, and timing of clinically relevant infection, each stratified by donor HIV status.RESULTS: The cumulative incidence of a clinically relevant infection at 24 months posttransplantation was 73.8% (95% confidence interval for HIV D+/R+ versus 64.7% (95% CI: 53.0%-73.4%) for HIV D-/R+. Comparing time to first clinically relevant infection in HIV D+/R+ versus HIV D-/R+, the adjusted hazard ratio (aHR) was 1.44 (95% CI: 1.01-2.04) at 24 months posttransplantation; for infections associated with hospitalization, the aHR was not significantly higher (1.21 [95% CI: .78-1.86). There were no significant differences in the number of infections, death from infection, duration, or site of infection between HIV D+/R+ versus HIV D-/R+, though viral infections were numerically more common in HIV D+/R+ (40% vs 35%).CONCLUSIONS: Although there was a statistically significant association between receipt of a kidney from a donor with HIV and time to first clinically relevant infection in the 24 months posttransplantation, there were no differences in infections associated with hospitalization. These data are overall reassuring as this emerging practice expands into clinical care. Clinical Trials Registration. NCT02602262.
SM
Dr. Sapna A. Mehta
Infectious Disease · Transplant/Immunocompromised StatesNYU Langone HealthsapnamNew York City, NY, USA